197 results on '"Wechalekar A"'
Search Results
2. Ascertaining the prognostic role of cardiac resynchronisation therapy in cardiac sarcoidosis: A comparison with ischaemic cardiomyopathy
3. Description and Cross-Sectional Analyses of 25,880 Adults and Children in the UK National Registry of Rare Kidney Diseases Cohort
4. Comparing outcomes of an ‘early’ versus ‘late’ diagnosis of cardiac sarcoidosis following a baseline presentation of high-grade atrioventricular block
5. Extensive cardiac FDG uptake in a patient with AL amyloidosis
6. Healthcare Resource Utilization and Cost-of-Illness in Systemic Light Chain (AL) Amyloidosis in Europe: Results From the Real-World, Retrospective EMN23 Study
7. Characterisation and management of expected and unexpected urgent findings from positron emission tomography with 18F-fluorodeoxyglucose integrated with computed tomography in cardiovascular disease
8. Role of serial 18F-fludeoxyglucose positron emission tomography in determining the therapeutic efficacy of immunosuppression and clinical outcome in patients with cardiac sarcoidosis
9. Racial disparities among patients with cardiac sarcoidosis and arrhythmias in the United States: A propensity matched-analysis from the national inpatient sample database 2016-2020
10. Complete responses in AL amyloidosis are unequal: the impact of free light chain mass spectrometry in AL amyloidosis
11. Birtamimab plus standard of care in light-chain amyloidosis: the phase 3 randomized placebo-controlled VITAL trial
12. A rare case of extensive biventricular cardiac sarcoidosis with reversible torrential tricuspid regurgitation
13. Real-World Efficacy of Tafamidis in Patients With Transthyretin Amyloidosis and Heart Failure
14. Normative Values for Pinch Strength—Relationship With Joint Hypermobility as Measured With the Beighton Criteria
15. Daratumumab in AL amyloidosis
16. Outcomes by Cardiac Stage in Patients With Newly Diagnosed AL Amyloidosis: Phase 3 ANDROMEDA Trial
17. AL Amyloidosis for Cardiologists: Awareness, Diagnosis, and Future Prospects: JACC: CardioOncology State-of-the-Art Review
18. Search for AL amyloidosis risk factors using Mendelian randomization
19. Systemic Amyloidosis due to Low-Grade Lymphoma
20. Standardized reporting of monoclonal immunoglobulin–associated renal diseases: recommendations from a Mayo Clinic/Renal Pathology Society Working Group
21. Daratumumab plus CyBorD for patients with newly diagnosed AL amyloidosis: safety run-in results of ANDROMEDA
22. Cardiac sarcoidosis with complete metabolic response and resolution of left ventricular dysfunction complicated by subsequent VT storm
23. Noncontrast Magnetic Resonance for the Diagnosis of Cardiac Amyloidosis
24. A prospective observational study of 915 patients with systemic AL amyloidosis treated with upfront bortezomib
25. Intersoftware variability impacts classification of cardiac PET exams
26. Cardiac Structural and Functional Consequences of Amyloid Deposition by Cardiac Magnetic Resonance and Echocardiography and Their Prognostic Roles
27. Pre-surgical Evaluation of Lung Function
28. Response to Letter to the Editor
29. Outcome of Patients With Newly Diagnosed Systemic Light-Chain Amyloidosis Associated With Deletion of 17p
30. Molecular genetic investigation, clinical features, and response to treatment in 21 patients with Schnitzler syndrome
31. IDH-mutant myeloid neoplasms are associated with seronegative rheumatoid arthritis and innate immune activation
32. Prolonged renal survival in light chain amyloidosis: speed and magnitude of light chain reduction is the crucial factor
33. Applications of Ventilation-Perfusion Scintigraphy in Surgical Management of Chronic Obstructive Lung Disease and Cancer
34. Renal Amyloidosis Associated With 5 Novel Variants in the Fibrinogen A Alpha Chain Protein
35. Redistribution of myocardial perfusion after coronary sinus reducer implantation demonstrated by rubidium-82 positron emission tomography
36. Kiosk 1R-FB-04 - Cardiovascular Magnetic Resonance (CMR) in Transthyretin Amyloid Cardiomyopathy – a Study of Natural History of Treatment Response
37. Kiosk 5R-TB-04 - Cardiac Magnetic Resonance (CMR) and 18F-FDG Positron Emission Tomography (PET) Imaging in Suspected Immune Checkpoint Inhibitor (ICI)-associated Myocarditis
38. Treatment recommendations from the Eighth International Workshop on Waldenström's Macroglobulinemia
39. Natural history and outcome of light chain deposition disease
40. Assessment of an intermediate reprojection technique transitioning from planar to SPECT radionuclide ventriculography
41. Native T1 Mapping in Transthyretin Amyloidosis
42. CMR-Based Differentiation of AL and ATTR Cardiac Amyloidosis
43. Efficacy and Safety of Belantamab Mafodotin Monotherapy in Patients with Relapsed or Refractory Light Chain Amyloidosis: A Phase 2 Study By the European Myeloma Network
44. Use of Matrix-Assisted Laser Desorption/Ionisation Time-of-Flight Mass Spectrometry (MALDI-TOF MS) Free Light Chain Assessment for the Diagnosis and Monitoring of Systemic Immunoglobulin Light Chain (AL) Amyloidosis
45. Systemic light chain amyloidosis: an update for treating physicians
46. A European collaborative study of treatment outcomes in 346 patients with cardiac stage III AL amyloidosis
47. Renal Transplantation in Systemic Amyloidosis—Importance of Amyloid Fibril Type and Precursor Protein Abundance
48. Outcomes by Cardiac Stage in Patients With Newly Diagnosed AL Amyloidosis: Phase 3 ANDROMEDA Trial
49. Amyloidogenicity and Clinical Phenotype Associated with Five Novel Mutations in Apolipoprotein A-I
50. High Incidence of Secondary Malignancy after Allogeneic Hematopoietic Stem Cell Transplant in Adults: A Call for Surveillance
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.